Cargando…
Repositioning chlorpromazine for treating chemoresistant glioma through the inhibition of cytochrome c oxidase bearing the COX4-1 regulatory subunit
Patients with glioblastoma have one of the lowest overall survival rates among patients with cancer. Standard of care for patients with glioblastoma includes temozolomide and radiation therapy, yet 30% of patients do not respond to these treatments and nearly all glioblastoma tumors become resistant...
Autores principales: | Oliva, Claudia R., Zhang, Wei, Langford, Cathy, Suto, Mark J., Griguer, Corinne E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514931/ https://www.ncbi.nlm.nih.gov/pubmed/28455961 http://dx.doi.org/10.18632/oncotarget.17247 |
Ejemplares similares
-
Effect of Expression of Nuclear-Encoded Cytochrome C Oxidase Subunit 4 Isoforms on Metabolic Profiles of Glioma Cells
por: Oliva, Claudia R., et al.
Publicado: (2022) -
Nuclear-encoded cytochrome c oxidase subunit 4 regulates BMI1 expression and determines proliferative capacity of high-grade gliomas
por: Oliva, Claudia R., et al.
Publicado: (2015) -
Acquisition of Chemoresistance in Gliomas Is Associated with Increased Mitochondrial Coupling and Decreased ROS Production
por: Oliva, Claudia R., et al.
Publicado: (2011) -
CG7630 is the Drosophila melanogaster homolog of the cytochrome c oxidase subunit COX7B
por: Brischigliaro, Michele, et al.
Publicado: (2022) -
Prognostic Relevance of Cytochrome c Oxidase in Primary Glioblastoma Multiforme
por: Griguer, Corinne E., et al.
Publicado: (2013)